MZF1 has positive regulation on CDC37 gene transcription by binding the regulatory sites, while MZF1 deletion reduces CDC37 transcription and tumorigenicity of prostate cancer cells [48]. This evidence concerns the gene MZF1 and prostate carcinoma.